Commentary | Published:

The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine

Nature Medicine volume 17, pages 12171220 (2011) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Creation and revelation: two different routes to advancement in the biomedical sciences. Nat. Med. 13, 1151–1154 (2007).

  2. 2.

    Collaboration Research Group for Qinghaosu. A new sesquiterpene lactone—qinghaosu [in Chinese]. Kexue Tongbao 3, 142 (1977).

  3. 3.

    et al. Structure and reaction of qinghaosu [in Chinese]. Acta Chimi. Sin. 37, 129–143 (1979).

  4. 4.

    Collaboration research group for Qinghaosu. Studies on new anti-malarial drug qinghaosu [in Chinese]. Yaoxue Tongbao 14, 49–53 (1979).

  5. 5.

    Collaboration research group for Qinghaosu. Antimalarial studies on qinghaosu [in Chinese]. Chin. Med. J. 92, 811–816 (1979).

  6. 6.

    The awarded Chinese invention: antimalarial drug qinghaosu [in Chinese]. Rev. World Invent. 4, 26 (1981).

  7. 7.

    et al. Studies on the constituents of Artemisia annua L [in Chinese]. Yao Xue Xue Bao 16, 366–370 (1981).

  8. 8.

    , , & Studies on the constituents of Artemisia annua L. and derivatives of artemisinin [in Chinese]. Zhongguo Zhong Yao Za Zhi 6, 31 (1981).

  9. 9.

    et al. Studies on the constituents of Artemisia annua L. (II). Planta Med. 44, 143–145 (1982).

  10. 10.

    Collaboration Research Group for Qinghaosu. Chemical studies on qinghaosu. J. Tradit. Chin. Med. 2, 3–8 (1982).

  11. 11.

    & Isolation and identification of the lipophilic constituents from Artemisia anomala S. Moore [in Chinese]. Yao Xue Xue Bao 19, 909–913 (1984).

  12. 12.

    , , , & Studies on the constituents of Artemisia annua L. (III) [in Chinese]. Chin. Tradit. Herbal Drugs 16, 200–201 (1985).

  13. 13.

    & Studies on the constituents of Artemisia apiacea Hance [in Chinese]. Chin. Tradit. Herbal Drugs 6, 2–3 (1985).

  14. 14.

    , & Studies on the constituents of Young Artemisia annua L [in Chinese]. Zhongguo Zhong Yao Za Zhi 10, 419–420 (1985).

  15. 15.

    & Studies on the constituents of Artemisia gmelinii Web.exstechm [in Chinese]. Chin. Bull. Bot. 3, 34–37 (1985).

  16. 16.

    & Studies on the constituents of Artemisia argyi Levl et vant [in Chinese]. Zhongguo Zhong Yao Za Zhi. 10, 31–32 (1985).

  17. 17.

    & Isolation and identification of the lipophilic constituents from Artemisia anomala S. Moore [in Chinese]. Acta Bot. Sin. 28, 307–310 (1986).

  18. 18.

    Study on authentic species of Chinese herbal drug winghao [in Chinese]. Bull. Chin. Mater. Med. 12, 2–5 (1987).

  19. 19.

    & Studies on the constituents of Artemisia eriopoda Bunge [in Chinese]. Chin. Tradit. Herbal Drugs 20, 149–150 (1989).

  20. 20.

    & Studies on chemical constituents of Artemisia japonica Thunb [in Chinese]. Chin. Tradit. Herbal Drugs 24, 122–124 (1993).

  21. 21.

    Qinghaosu (artemisinin): an antimalarial drug from China. Science 228, 1049–1055 (1985).

  22. 22.

    et al. Experimental study on the immunosuppressive effects of qinghaosu and its derivatives [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 11, 37–38 (1993).

  23. 23.

    , , , & Immunologic enhancement and reconstitution by qinghaosu and its derivatives [in Chinese]. Chin. Bull. Pharm 9, 61–63 (1992).

  24. 24.

    , , , & Effect of dihydroqinghaosu on the development of Plasmodium yoelii in Anopheles stephensi [in Chinese]. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 16, 421–424 (1998).

  25. 25.

    et al. Studies on the antipyretic and anti-inflammatory effects of Artemisia annua L [in Chinese]. Zhongguo Zhong Yao Za Zhi 18, 44–48 (1993).

  26. 26.

    The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu. Chin. Med. J. 112, 976–977 (1999).

  27. 27.

    , & Effect of hydroartemisinin on lupus BXSB mice [in Chinese]. Chin. J. Dermatovenerol. Integr. Tradit. West. Med. 1, 19–20 (2002).

  28. 28.

    et al. Effect of dihydro-qinghaosu on auto-antibody production, TNFa secretion and pathologic change of lupus nephritis in BXSB mice [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 23, 676–679 (2003).

  29. 29.

    et al. The effects of DQHS on the pathologic changes in BXSB mice lupus nephritis and the effect mechanism [in Chinese]. Chin. Pharmacol. Bull. 19, 1125–1128 (2003).

  30. 30.

    The development of the antimalarial drugs with new type of chemical structure—qinghaosu and dihydroqinghaosu. Southeast Asian J. Trop. Med. Public Health 35, 250–251 (2004).

  31. 31.

    , , & Determination of scopoletin in qinghao by HPLC [in Chinese]. Chin. J. Exp. Tradit. Med. Formulae 12, 10–11 (2006).

  32. 32.

    , , & Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int. Immunopharmacol. 6, 1243–1250 (2006).

  33. 33.

    , , , & Determination of artemisinin, arteannuin B and artemisinic acid in Artemisia annua by HPLC-UV-ELSD [in Chinese]. Yao Xue Xue Bao 42, 978–981 (2007).

  34. 34.

    Qinghao Ji Qinghaosulei Yaowu (Artemisia annua L., Artemisinin and its Derivatives) [in Chinese] (ed. Tu, Y.Y.) (Publisher of Chemical Industry, Beijing, 2009).

  35. 35.

    et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89, 3345–3353 (1997).

  36. 36.

    et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328, 240–243 (2010).

  37. 37.

    & Pharmacological profile of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb. CNS Drug Rev. 5, 281–300 (1999).

  38. 38.

    et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin. Med. J. 119, 6–13 (2006).

  39. 39.

    et al. The effect of Xuefu Zhuyu decoction on in vitro endothelial progenitor cell tube formation. Chin. J. Integr. Med. 16, 50–53 (2010).

  40. 40.

    et al. Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. Am. J. Physiol. Heart Circ. Physiol. 298, H1166–H11176 (2010).

  41. 41.

    et al. The antioxidant Cerebralcare Granule attenuates cerebral microcirculatory disturbance during ischemia-reperfusion injury. Shock 32, 201–209 (2009).

  42. 42.

    et al. Cerebralcare Granule, a Chinese herb compound preparation, improves cerebral microcirculatory disorder and hippocampal CA1 neuron injury in gerbils after ischemia–reperfusion. J. Ethnopharmacol. 130, 398–406 (2010).

  43. 43.

    et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol. Ther. 117, 280–295 (2008).

  44. 44.

    et al. Biomechanopharmacology: a new borderline discipline. Trends Pharmacol. Sci. 27, 287–289 (2006).

  45. 45.

    et al. Joint preventive effects of swimming and Shenlian extract on rat atherosclerosis. Clin. Hemorheol. Microcirc. 47, 187–198 (2011).

  46. 46.

    et al. The effect of salvianolic acid B combined with laminar shear stress on TNF-alpha-stimulated adhesion molecule expression in human aortic endothelial cells. Clin. Hemorheol. Microcirc. 44, 245–258 (2010).

Download references

Acknowledgements

I wish to express my heartfelt thanks to all my colleagues at the Academy of Traditional Chinese Medicine for their devotion to our work and for their exceptional contributions to the discovery and application of artemisinin and its derivatives. I thank my colleagues in the Shangdong Provincial Institute of Chinese Medicine, the Yunnan Provincial Institute of Materia Medica, the Institute of Biophysics and the Shanghai Institute of Organic Chemistry at the Chinese Academy of Sciences, Guangzhou University of Chinese Medicine and the Academy of Military Medical Sciences for their significant contributions to Project 523. I also would pay my respects to the leadership at the national Project 523 office and their sound efforts in organizing the malaria project activities.

Author information

Affiliations

  1. Youyou Tu is at the Qinghaosu Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

    • Youyou Tu

Authors

  1. Search for Youyou Tu in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Youyou Tu.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm.2471

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing